We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Magnetic Ray Gun Zaps Migraine Pain

By HospiMedica staff writers
Posted on 08 Jul 2008
A new experimental device dubbed "the migraine zapper” has been found to be safe and effective in eliminating headaches when administered during the onset of the migraine, and has no side effects, according to a new study. More...


Researchers at Ohio State University (OSU, Columbus, USA) developed the noninvasive transcranial magnetic stimulator (TMS) device, which interrupts the aura phase of the migraine--often described as electrical storms in the brain-- by sending a magnetic pulse through the brain before it leads to headaches. The TMS device sends a strong electric current through a metal coil, which creates an intense magnetic field for about one millisecond. This magnetic pulse, when held against a person's head, creates an electric current in the neurons of the brain, interrupting the aura before it results in a throbbing headache. The study results showed that of the 164 patients involved in a multi-center, randomized clinical trial receiving TMS treatment, 39% were pain free at the two-hour post-treatment point, compared to 22% in the group receiving sham pulses. There were no differences reported related to adverse reactions between the two groups.
The study was presented at the annual American Headache Society (AHS) meeting, held during June 2008 in Boston (MA, USA).

"Stimulation with magnetic pulses from the portable TMS device proved effective for the migraine patients,” said principal investigator Yousef Mohammad, M.D., a neurologist at OSU Medical Center. "Because of the lack of adverse events in this trial and the established safety of the TMS device, this is a promising treatment for migraines with aura.”

"Since almost all migraine drugs have some side effects, and patients are prone to addiction from narcotics, or developing headaches from frequent use of over-the-counter medication, the TMS device holds great promise for migraine sufferers,” added Dr. Mohammad.

Migraine headaches were previously believed to start with vascular constriction, which results in an aura, followed by vascular dilation that leads to a throbbing headache. However, in the late 1990's it was suggested alternatively that neuronal electrical hyper-excitability resulted in a throbbing headache. This new understanding of the migraine mechanism assisted in the development of the TMS device.


Related Links:
Ohio State University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.